We evaluated MHC-class I-restricted CTL responses induced by HIV-1 clade B-
based vaccines in nine HIV-1 seronegative vaccine recipients with regard to
their patterns of HLA restriction and epitope recognition. We found that s
even of nine volunteers developed detectable CTL reactivities against novel
epitopes within the HIV-1 Env and Gag proteins. Although four of nine subj
ects were HLA-A*0201, none of the cellular responses was restricted in the
context of this allele. The type of responses observed in this sampling of
vaccines appeared similar to those reported during primary infection and am
ong long term non-progressors, with three out of nine subjects recognizing
HLA-B27 or HLA-B17(57)-restricted epitopes. Although the majority of CTL re
sponses were directed against novel epitopes, these effectors were still ab
le to mediate cross-clade reactivities. (C) 2001 Elsevier Science B.V. All
rights reserved.